Ryan Martins 89bio, Inc. (ETNB) insider trading activity

Ryan Martins is Chief Financial Officer of 89bio, Inc.. Currently has a direct ownership of 106,609 shares of ETNB, which is worth approximately $810,228. The most recent transaction as insider was on Feb 17, 2024, when has been sold 778 shares (Common Stock) at a price of $9.74 per share, resulting in proceeds of $7,577. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K

0% 3M change

85.75% 12M change

Total Value Held $810,228

Ryan Martins Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2024	SELL Payment of exercise price or tax liability	$7,577 $9.74 p/Share	778 Reduced 0.72%	106,609 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$30,149 $8.45 p/Share	3,568 Reduced 3.22%	107,387 Common Stock
Feb 05 2024	SELL Payment of exercise price or tax liability	$8,741 $9.8 p/Share	892 Reduced 0.8%	110,955 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	48,750 Added 30.36%	111,847 Common Stock
Jan 05 2024	SELL Payment of exercise price or tax liability	$70,609 $11.53 p/Share	6,124 Reduced 8.85%	63,097 Common Stock
Jan 05 2024	BUY Grant, award, or other acquisition	-	15,000 Added 17.81%	69,221 Common Stock
Sep 09 2023	SELL Payment of exercise price or tax liability	$34,449 $16.61 p/Share	2,074 Reduced 3.68%	54,221 Common Stock

Aug 17 2023	SELL Payment of exercise price or tax liability	$11,641 $15.46 p/Share	753 Reduced 1.32%	56,295 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$5,411 $15.64 p/Share	346 Reduced 0.6%	57,048 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$38,241 $18.95 p/Share	2,018 Reduced 3.4%	57,394 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	5,834 Added 8.94%	59,412 Common Stock
Apr 04 2023	SELL Open market or private sale	$130,378 $14.95 p/Share	8,721 Reduced 14.0%	53,578 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$70,240 $15.23 p/Share	4,612 Reduced 6.89%	62,299 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	13,333 Added 17.04%	64,893 Common Stock
Mar 23 2023	SELL Open market or private sale	$80,550 $16.11 p/Share	5,000 Reduced 8.54%	53,578 Common Stock
Feb 21 2023	SELL Open market or private sale	$35,280 $13.89 p/Share	2,540 Reduced 4.16%	58,578 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$24,447 $13.97 p/Share	1,750 Reduced 2.78%	61,118 Common Stock
Feb 09 2023	BUY Grant, award, or other acquisition	-	30,000 Added 32.3%	62,868 Common Stock
Feb 08 2023	SELL Open market or private sale	$21,326 $14.41 p/Share	1,480 Reduced 4.31%	32,868 Common Stock
Feb 05 2023	SELL Payment of exercise price or tax liability	$7,838 $13.24 p/Share	592 Reduced 1.69%	34,348 Common Stock
Feb 03 2023	SELL Open market or private sale	$46,372 $12.91 p/Share	3,592 Reduced 9.22%	35,368 Common Stock
Feb 03 2023	BUY Exercise of conversion of derivative security	$9,330 $3.11 p/Share	3,000 Added 7.15%	38,960 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$4,916 $12.05 p/Share	408 Reduced 1.12%	35,960 Common Stock
Jan 03 2023	SELL Open market or private sale	$74,396 $12.51 p/Share	5,947 Reduced 14.05%	36,368 Common Stock
Sep 28 2022	SELL Payment of exercise price or tax liability	$11,624 $5.76 p/Share	2,018 Reduced 4.55%	42,315 Common Stock

Ryan Martins

Chief Financial Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETNB shares.

Notify only if

Value

Insider Trading

Get notified when an 89bio, Inc. insider buys or sells ETNB shares.

Notify only if

Operation

Value

Type

News

Receive news related to 89bio, Inc.

Track Activities on ETNB

Account